← SynDRA
Bay-85-8501
SynDRA canonical compound SYN1612707 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ELANE |
|---|
| Mechanism of action | elastase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- U9DE68P1CA
- RefChem:116711
- UNII-U9DE68P1CA
- YAJWYFPMASPAMM-HXUWFJFHSA-N
- SCHEMBL121431
- orb1309191
- SCHEMBL29443698
- SCHEMBL29636980
- GLXC-23208
- BDBM50120437
- AKOS040736087
- T12613L
- BB166655
- DA-71319
- HY-19908
- MS-28800
- CS-0016945
- G15935
- (4S)-4-(4-cyano-2-methylsulfonylphenyl)-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carbonitrile
- YAJWYFPMASPAMM-UHFFFAOYSA-N
- BAY-85-8501 Racemate
- CS-0078495
- SCHEMBL3663656
- SB19620
- SCHEMBL29709949
- BAY-85-8501 (racemic)
- WXD17539
Look up Bay-85-8501 in the interactive SynDRA portal →